ClinVar Miner

Submissions for variant NM_001347721.2(DYRK1A):c.1010C>T (p.Ser337Phe) (rs1555985649)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000601140 SCV000712522 likely pathogenic Mental retardation, autosomal dominant 7 2016-10-19 criteria provided, single submitter clinical testing The p.Ser346Phe variant in DYRK1A was absent from large population studies and h as been detected in one individual with a range of phenotypic manifestations inc luding intellectual disability, seizures and microcephaly (TIDEX study, m.) It reportedly was not detected in the unaffected parents, which increases th e likelihood that it is pathogenic. A different amino acid change at the same po sition (p.Ser346Pro) has been identified as a de novo variant in 2 individuals w ith intellectual disability, autism, and microcephaly (Bronicki 2015, DDDS 2015) , further supporting that a change at this position may not be tolerated. This i s consistent with computational predictions that suggest an impact to the protei n. Finally, the DYRK1A gene is associated with "DYRK1A-related intellectual disa bility syndrome with all cases reported to date resulting from a de novo variant ( In summary, the available evi dence suggests that the Ser346Phe variant is likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.